Shanghai, China

Xin Ma

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Jing Medicine Technology (Shanghai) Ltd., Shanghaitech University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Ma. Retrieved from https://idiyas.com/inventor/xin-ma-m3batdub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xin Ma - Innovator in Pharmaceutical Development

Introduction

Xin Ma is an accomplished inventor based in Shanghai, China. He is currently associated with GlaxoSmithKline Intellectual Property Development Limited. Despite having no patents to his name, his contributions to the field of pharmaceutical development are noteworthy.

Latest Patents

As of now, Xin Ma has not registered any patents. This does not diminish his role in the innovative processes at his company.

Career Highlights

Xin Ma has made significant strides in his career at GlaxoSmithKline Intellectual Property Development Limited. His work focuses on enhancing the intellectual property landscape within the pharmaceutical industry. He collaborates closely with his colleagues to drive innovation and improve product development.

Collaborations

Xin Ma works alongside talented individuals such as Jing Deng and Hui Lei. Their combined expertise fosters a collaborative environment that encourages innovative solutions in pharmaceutical research.

Conclusion

Xin Ma's journey in the pharmaceutical sector highlights the importance of collaboration and innovation, even in the absence of patents. His work continues to contribute to advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…